Subscribe To
Oncocyte to announce third quarter 2023 financial results
Conference Call and Webcast on Thursday, November 9, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Onco...
November 3, 2023, 12:30 pm
Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann
Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for t...
November 3, 2023, 10:00 am
Incyte (incy) beats on q3 earnings, misses revenue estimates
Incyte's (INCY) third-quarter 2023 earnings beat estimates, while revenues miss the same. The company t...
October 31, 2023, 1:31 pm
Incyte corporation (incy) q3 2023 earnings call transcript
Incyte Corporation (NASDAQ:INCY ) Q3 2023 Earnings Call Transcript October 31, 2023 8:00 AM ET Company ...
October 31, 2023, 12:23 pm
Earnings preview: cytek biosciences, inc. (ctkb) q3 earnings expected to decline
cytek Biosciences, Inc. (CTKB) doesn't possess the right combination of the two key ingredients for a l...
October 31, 2023, 11:18 am
Drugmaker incyte's quarterly profit beats on lower costs
Incyte reported a third-quarter profit on Tuesday that beat analysts' estimates as lower costs helped o...
October 31, 2023, 9:48 am
Incyte (incy) surpasses q3 earnings estimates
Incyte (INCY) came out with quarterly earnings of $1.10 per share, beating the Zacks Consensus Estimate...
October 31, 2023, 9:46 am
Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting
SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, dev...
October 31, 2023, 9:05 am
Zyversa therapeutics announces a publication in the peer-reviewed journal, aging, linking inflammasome nlrp3 activation with age-related structural changes in the kidney and reduced kidney function
Chronic kidney disease is most common in people 65 years and older. NLRP3 inflammasomes signaling in the kidneys’ filtration system (“glomerular p...
October 18, 2023, 11:05 am
Tscan therapeutics: that recent amgen deal is the only point of interest
TScan Therapeutics is developing TCR T-cell therapies for cancer using a transposon-based T cell engineering method. The company aims to target a broa...
October 14, 2023, 3:32 am
Incyte (incy) stock plummets 29.6% year to date: here's why
Incyte (INCY) loses 29.6% year-to-date as competition increases for Jakafi and the company suffers pipe...
October 13, 2023, 2:16 pm
Incyte (incy) posts upbeat data from phase ii vitiligo study
Incyte (INCY) announces new positive 52-week data from its mid-stage study of povorcitinib for the trea...
October 12, 2023, 12:47 pm
Novartis leads funding round for uk alzheimer's specialist
UK-based biotech firm AstronauTx has secured £48 million ($61 million) in a significant Series A funding round, marking a step towards developing tre...
October 9, 2023, 2:16 am
Why shares of maxcyte are plummeting on thursday
Maxcyte focuses on cell-engineering platform technology. The company blamed lower orders for a likely r...
October 5, 2023, 12:59 pm
Why is maxcyte (mxct) stock down 21% today?
Maxcyte (NASDAQ: MXCT ) stock is sliding lower on Thursday following the release of preliminary earnin...
October 5, 2023, 8:47 am
Incyte to present multiple studies from dermatology portfolio at 2023 european academy of dermatology and venereology (eadv) congress
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte to Present Multiple Studies from Dermatology Portfo...
September 29, 2023, 1:43 pm
Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting
SAN CARLOS, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, de...
September 27, 2023, 4:01 pm
cytek biosciences to participate in the 2023 cantor fitzgerald global healthcare conference
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — cytek Biosciences, Inc. (Nasdaq: CTKB), a leading ...
September 20, 2023, 8:15 pm
Incyte (incy) down on fda nod for another myelofibrosis drug
Incyte (INCY) declines on potential competition for lead drug Jakafi from Ojjaara for the treatment of ...
September 19, 2023, 9:46 am
cyteir: although the company is winding down, the lead asset had promise
cyteir is a developer of cancer therapeutics that has decided to suspend operations and sell all assets...
September 18, 2023, 5:32 pm